Document is current
Any future updates will be listed below
-
Authors
Hua, Yijun
You, Rui https://orcid.org/0000-0001-9362-8144
Wang, Zhiqiang
Huang, Peiyu
Lin, Mei https://orcid.org/0000-0003-0275-9144
Ouyang, Yanfeng
Xie, Yulong
Zou, Xiong
Liu, Youping
Duan, Chongyang
Liu, Yonglong
Gu, Chenmei
Liu, Rongzeng
Yang, Qi
Jiang, Rou
Zhang, Mengxia
Ding, Xi
Chen, Siyuan
Lin, Chao
Sun, Rui
Chen, Mingyuan
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03854838 at ClinicalTrials.govDocuments that mention this clinical trial
Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial
https://doi.org/10.1136/jitc-2021-003290
-
Funding
Funding for this research was provided by:
CSCO-JunShi Cancer Immunotherapy Clinical Research Fund (No. Y-JS2019-002)
the Special Support Program for High-level Talents in Sun Yat-sen University Cancer Center
the Guangzhou Science and Technology Plan Project (202103010001)
the National "Ten Thousand Talents Program" Science and Technology Innovation Leading Talents (84000-41180005)
National Natural Science Foundation of China (81772895)
National Natural Science Foundation of China (81874134)
National Natural Science Foundation of China (82002857)
the Key-Area Research and Development of Guangdong Province (2020B1111190001)
Program of Sun Yat-Sen University for Clinical Research 5010 Program (No. 2018015)
- License Information
